Skip to main content
Download PDF

Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma

BMC Medicine volume 23, Article number: 220 (2025) Cite this article

The Original Article was published on 04 September 2024

BMC Med 22, 365 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-024-03581-y


Following the publication of the original article [1], the authors wish to note that the affiliation for Xiaobing Chen in the original article should instead be as follows:

‘Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China’

Reference

  1. Wei M, et al. Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma. BMC Med. 2024;22:365. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-024-03581-y.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, No.270 Dong’An Road, Shanghai, 200032, China

    Miaoyan Wei, Jialin Li, Si Shi, Jin Xu & Xianjun Yu

  2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    Miaoyan Wei, Rujiao Liu, Shuiping Gao, Jialin Li, Jian Zhang, Si Shi, Jin Xu & Xianjun Yu

  3. Shanghai Pancreatic Cancer Institute, Shanghai, China

    Miaoyan Wei, Jialin Li, Si Shi, Jin Xu & Xianjun Yu

  4. Pancreatic Cancer Institute, Fudan University, Shanghai, China

    Miaoyan Wei, Jialin Li, Si Shi, Jin Xu & Xianjun Yu

  5. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

    Rujiao Liu, Shuiping Gao & Jian Zhang

  6. Department of Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China

    Rujiao Liu, Shuiping Gao & Jian Zhang

  7. Department of General Surgery, Cancer Center, Division of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China

    Yunyun Xu

  8. Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China

    Xiaobing Chen

  9. Department of Hepato-Pancreato-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Guangzhou, China

    Chao Liu

  10. Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    Xueli Bai & Xiaochen Zhang

  11. Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China

    Zhen Sheng, Jianpo Lian & Wenliang Wang

Authors
  1. Miaoyan Wei
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Rujiao Liu
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Yunyun Xu
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Xiaobing Chen
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Chao Liu
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Xueli Bai
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Xiaochen Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Shuiping Gao
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Jialin Li
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Zhen Sheng
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Jianpo Lian
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Wenliang Wang
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. Jian Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. Si Shi
    View author publications

    You can also search for this author inPubMed Google Scholar

  15. Jin Xu
    View author publications

    You can also search for this author inPubMed Google Scholar

  16. Xianjun Yu
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence to Si Shi, Jin Xu or Xianjun Yu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, M., Liu, R., Xu, Y. et al. Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma. BMC Med 23, 220 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-025-04078-y

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-025-04078-y

BMC Medicine

ISSN: 1741-7015

Contact us